메뉴 건너뛰기




Volumn 18, Issue 6, 2008, Pages 347-351

Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection

Author keywords

Chronic hepatitis C; Hyperthyroidism; Hypothyroidism; Interferon; Ribavirin; Thyroid hormone

Indexed keywords

ALPHA2B INTERFERON; HEPATITIS C ANTIBODY; LEVOTHYROXINE; LIOTHYRONINE; PROPRANOLOL; RIBAVIRIN; THYROTROPIN; THYROXINE; VIRUS RNA;

EID: 49749114857     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)

References (31)
  • 1
    • 0034791598 scopus 로고    scopus 로고
    • The spectrum of liver disease in the general population: Lesson from the Dionysos study
    • Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001; 35:531-7.
    • (2001) J Hepatol , vol.35 , pp. 531-537
    • Bellentani, S.1    Tiribelli, C.2
  • 2
    • 0036828783 scopus 로고    scopus 로고
    • Course and outcome of hepatitis C
    • Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (5 suppl 1): S21-9.
    • (2002) Hepatology , vol.36 , Issue.5 SUPPL. 1
    • Hoofnagle, J.H.1
  • 5
    • 0030886005 scopus 로고    scopus 로고
    • Side-effects of alpha interferon in chronic hepatitis C
    • Dusheiko G. Side-effects of alpha interferon in chronic hepatitis C. Hepatology 1997; 26 (3 suppl 1): 112S-121S.
    • (1997) Hepatology , vol.26 , Issue.3 SUPPL. 1
    • Dusheiko, G.1
  • 6
  • 7
    • 0030279780 scopus 로고    scopus 로고
    • Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha
    • Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996; 101:482-7.
    • (1996) Am J Med , vol.101 , pp. 482-487
    • Roti, E.1    Minelli, R.2    Giuberti, T.3    Marchelli, S.4    Schianchi, C.5    Gardini, E.6
  • 9
    • 0032999613 scopus 로고    scopus 로고
    • HLA antigens in patients with interferon-alpha induced autoimmune thyroid disorders in chronic hepatitis C
    • Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M. HLA antigens in patients with interferon-alpha induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol 1999; 30: 794-800.
    • (1999) J Hepatol , vol.30 , pp. 794-800
    • Kakizaki, S.1    Takagi, H.2    Murakami, M.3    Takayama, H.4    Mori, M.5
  • 11
    • 0036498601 scopus 로고    scopus 로고
    • A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms non-destructive to destructive thyroiditis in experimental autoimmune thyroiditis
    • Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms non-destructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 2002; 168: 2470-4.
    • (2002) J Immunol , vol.168 , pp. 2470-2474
    • Wang, S.H.1    Bretz, J.D.2    Phelps, E.3    Mezosi, E.4    Arscott, P.L.5    Utsugi, S.6
  • 12
    • 0031465313 scopus 로고    scopus 로고
    • Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature
    • Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997; 7:891-6.
    • (1997) Thyroid , vol.7 , pp. 891-896
    • Koh, L.K.1    Greenspan, F.S.2    Yeo, P.P.3
  • 13
    • 0038168312 scopus 로고    scopus 로고
    • Interferon-alpha and autoimmune thyroid disease
    • Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid 2003; 13: 547-51.
    • (2003) Thyroid , vol.13 , pp. 547-551
    • Prummel, M.F.1    Laurberg, P.2
  • 14
    • 0032527967 scopus 로고    scopus 로고
    • Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis B before, during, and after discontinuing interferon therapy
    • Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158: 1445-8.
    • (1998) Arch Intern Med , vol.158 , pp. 1445-1448
    • Fernandez-Soto, L.1    Gonzalez, A.2    Escobar-Jimenez, F.3    Vazquez, R.4    Ocete, E.5    Olea, N.6
  • 15
    • 0034119793 scopus 로고    scopus 로고
    • Virologic factors related to interferon-alpha induced thyroid dysfunction in patients with chronic hepatitis C
    • Hsieh MC, Yu ML, Chuang WL, Shin SJ, Dai CY, Chen SC, et al. Virologic factors related to interferon-alpha induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 2000; 142:431-7.
    • (2000) Eur J Endocrinol , vol.142 , pp. 431-437
    • Hsieh, M.C.1    Yu, M.L.2    Chuang, W.L.3    Shin, S.J.4    Dai, C.Y.5    Chen, S.C.6
  • 16
    • 0028266831 scopus 로고
    • The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C
    • Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89:399-403.
    • (1994) Am J Gastroenterol , vol.89 , pp. 399-403
    • Watanabe, U.1    Hashimoto, E.2    Hisamitsu, T.3    Obata, H.4    Hayashi, N.5
  • 17
    • 0036091858 scopus 로고    scopus 로고
    • Thyroid dysfunction during treatment of chronic hepatitis C with interferon-alpha: No association with either interferon dosage or efficacy of therapy
    • Dalgard O, Bjoro K, Hellum K, Myrvang B, Bjoro T, Haug E, et al. Thyroid dysfunction during treatment of chronic hepatitis C with interferon-alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med 2002; 251:400-6.
    • (2002) J Intern Med , vol.251 , pp. 400-406
    • Dalgard, O.1    Bjoro, K.2    Hellum, K.3    Myrvang, B.4    Bjoro, T.5    Haug, E.6
  • 18
    • 0032055507 scopus 로고    scopus 로고
    • Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
    • Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998; 160:3487-93.
    • (1998) J Immunol , vol.160 , pp. 3487-3493
    • Ning, Q.1    Brown, D.2    Parodo, J.3    Cattral, M.4    Gorczynski, R.5    Cole, E.6
  • 19
    • 0031663638 scopus 로고    scopus 로고
    • The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses
    • Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998; 79 (pt 10):2381-91.
    • (1998) J Gen Virol , vol.79 , Issue.PART 10 , pp. 2381-2391
    • Hultgren, C.1    Milich, D.R.2    Weiland, O.3    Sallberg, M.4
  • 20
    • 0036299570 scopus 로고    scopus 로고
    • The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism
    • Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol 2002; 146:743-9.
    • (2002) Eur J Endocrinol , vol.146 , pp. 743-749
    • Carella, C.1    Mazziotti, G.2    Morisco, F.3    Rotondi, M.4    Cioffi, M.5    Tuccillo, C.6
  • 21
    • 0030927636 scopus 로고    scopus 로고
    • Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon-alpha therapy
    • Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon-alpha therapy. Hepatology 1997; 26: 206-10.
    • (1997) Hepatology , vol.26 , pp. 206-210
    • Deutsch, M.1    Dourakis, S.2    Manesis, E.K.3    Gioustozi, A.4    Hess, G.5    Horsch, A.6
  • 23
    • 0031465313 scopus 로고    scopus 로고
    • Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature
    • Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997; 7: 891-6.
    • (1997) Thyroid , vol.7 , pp. 891-896
    • Koh, L.K.1    Greenspan, F.S.2    Yeo, P.P.3
  • 25
    • 33645291491 scopus 로고    scopus 로고
    • Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis
    • Kee KM, Lee CM, Wang JH, Tung HD, Changchien CS, Lu SN, et al. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. J Gastroenterol Hepatol 2006; 21 (1 pt 2): 319-26.
    • (2006) J Gastroenterol Hepatol , vol.21 , Issue.1 PART 2 , pp. 319-326
    • Kee, K.M.1    Lee, C.M.2    Wang, J.H.3    Tung, H.D.4    Changchien, C.S.5    Lu, S.N.6
  • 26
    • 4043145015 scopus 로고    scopus 로고
    • Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha
    • Foldes I, David K, Horvath G, Osztrogonacz H, Jankovics K, Tolvaj G. Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha. Orv Hetil 2004; 145:1211-6.
    • (2004) Orv Hetil , vol.145 , pp. 1211-1216
    • Foldes, I.1    David, K.2    Horvath, G.3    Osztrogonacz, H.4    Jankovics, K.5    Tolvaj, G.6
  • 27
    • 8844247779 scopus 로고    scopus 로고
    • Incidence of thyroid dysfunction during interferon-alpha-2b and ribavirin therapy in men with chronic hepatitis C: A prospective cohort study
    • Bini EJ, Mehandru S. Incidence of thyroid dysfunction during interferon-alpha-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study. Arch Intern Med 2004; 164: 2371-6.
    • (2004) Arch Intern Med , vol.164 , pp. 2371-2376
    • Bini, E.J.1    Mehandru, S.2
  • 28
    • 27644595245 scopus 로고    scopus 로고
    • The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha-2beta and Ribavirin
    • Oct 12;
    • Tran HA, Jones TL, Batey RG. The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha-2beta and Ribavirin. BMC Endocr Disord 2005 Oct 12; 5: 8.
    • (2005) BMC Endocr Disord , vol.5 , pp. 8
    • Tran, H.A.1    Jones, T.L.2    Batey, R.G.3
  • 30
    • 0034571359 scopus 로고    scopus 로고
    • Thyroid disease in HCV carriers undergoing antivirai therapy with interferon plus ribavirin
    • Parana R, Cruz M, Santos-Jesus R, Ferreira K, Codes L, Cruz T. Thyroid disease in HCV carriers undergoing antivirai therapy with interferon plus ribavirin. Braz J Infect Dis 2000; 4: 284-90.
    • (2000) Braz J Infect Dis , vol.4 , pp. 284-290
    • Parana, R.1    Cruz, M.2    Santos-Jesus, R.3    Ferreira, K.4    Codes, L.5    Cruz, T.6
  • 31
    • 0034846855 scopus 로고    scopus 로고
    • Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: Screening and monitoring recommendations
    • Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract 2001; 7: 52-8.
    • (2001) Endocr Pract , vol.7 , pp. 52-58
    • Ward, D.L.1    Bing-You, R.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.